Findings indicating that it plays a crucial role hippocampal neuron development and survival suggest that regulation of GSK3β could be a clinical target for neuropsychiatric disorders, such as depression and anxiety disorders [1, 4]. This evidence concerns the gene GSK3B and depressive disorder.